时间标签：数据日期 2026-11-03 · 生成时间 2026-11-03 05:30（Asia/Shanghai）｜ 检索窗口 PubMed edat 2026/10/31 – 2026/11/03 ｜ 情报发生日期 2026-11-03
研究问题
3 , 8 , 20 The aforementioned observations provide fertile ground to support and strengthen a working hypothesis that IRAs could be conceptualized as psychiatric drugs.；Tenets of a putative psychiatric drug include whether the agent affects molecular, cellular, circuit and network systems hypothesized to mediate and/or subserve the surface-based psychopathology that defines psychiatric disorders.；In addition, a related question is whether the drug has central nervous system (CNS) penetration and does it engage neural substrates?
方法
（原文未给出可直接抽取的对应表述）
核心结论
（原文未给出可直接抽取的对应表述）
局限
31 , 34 , 41 Hence, IRAs should be considered as contemporary treatments for many persons living with psychiatric disorders wherein cardiometabolic comorbidity affects the majority of persons with lived experience and excess mortality is an ignominious and potentially modifiable clinical target.；Additional analysis however, have suggested that the psychiatric benefits of IRAs may be partially, but not fully moderated by the presence of obesity and related morbidity suggesting putative direct effects on brain function and disease.
对本项目的价值
中等价值：属「衰弱 / 肌少症功能结局」方向；代谢 / 内分泌 / 肝肾老化的界面栏目可用作本项目文献库与综述素材。 ｜ 价值分 2.4/5（★★☆☆☆）
全文来源
PubMed PMC JATS（正文 13,058 字符，题名指纹 0.80，已过 DOI 逐字 + 题名指纹 + 正文长度三重归属校验）
原文题录
- 中文题名：肠促胰素受体激动剂是精神科药物吗：近期机会还是创意拔高
- 英文标题：Are Incretin Receptor Agonists Psychiatric Drugs: Near-term Opportunity or Creative Superlative?
- 期刊与标识：Psychiatry Clin Psychopharmacol · PMID 42964925 · DOI 10.65801/pcp.3528 · PMC PMC13720851 · EDAT 2026-10-31